A citation-based method for searching scientific literature

Stephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, Gilles Montalescot, Witold Ruzyllo, Shmuel Gottlieb, Franz-Joseph Neumann, Diego Ardissino, Stefano De Servi, Sabina A Murphy, Jeffrey Riesmeyer, Govinda Weerakkody, C Michael Gibson, Elliott M Antman. N Engl J Med 2007
Times Cited: 4421







List of co-cited articles
608 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
Lars Wallentin, Richard C Becker, Andrzej Budaj, Christopher P Cannon, Håkan Emanuelsson, Claes Held, Jay Horrow, Steen Husted, Stefan James, Hugo Katus,[...]. N Engl J Med 2009
75

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Stefanie Schüpke, Franz-Josef Neumann, Maurizio Menichelli, Katharina Mayer, Isabell Bernlochner, Jochen Wöhrle, Gert Richardt, Christoph Liebetrau, Bernhard Witzenbichler, David Antoniucci,[...]. N Engl J Med 2019
261
28

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
Roxana Mehran, Sunil V Rao, Deepak L Bhatt, C Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, Stephen D Wiviott, Venu Menon, Eugenia Nikolsky,[...]. Circulation 2011
26


Long-term use of ticagrelor in patients with prior myocardial infarction.
Marc P Bonaca, Deepak L Bhatt, Marc Cohen, Philippe Gabriel Steg, Robert F Storey, Eva C Jensen, Giulia Magnani, Sameer Bansilal, M Polly Fish, Kyungah Im,[...]. N Engl J Med 2015
22

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
S Yusuf, F Zhao, S R Mehta, S Chrolavicius, G Tognoni, K K Fox. N Engl J Med 2001
20

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Laura Mauri, Dean J Kereiakes, Robert W Yeh, Priscilla Driscoll-Shempp, Donald E Cutlip, P Gabriel Steg, Sharon-Lise T Normand, Eugene Braunwald, Stephen D Wiviott, David J Cohen,[...]. N Engl J Med 2014
18

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, Olivier Barthélémy, Johann Bauersachs, Deepak L Bhatt, Paul Dendale, Maria Dorobantu, Thor Edvardsen, Thierry Folliguet,[...]. Eur Heart J 2021
549
18

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
Roxana Mehran, Usman Baber, Samin K Sharma, David J Cohen, Dominick J Angiolillo, Carlo Briguori, Jin Y Cha, Timothy Collier, George Dangas, Dariusz Dudek,[...]. N Engl J Med 2019
334
16

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
Daniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, Renicus S Hermanides, Arnoud W J van 't Hof, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M Tjon Joe Gin, Folkert W Asselbergs,[...]. N Engl J Med 2019
182
16


2018 ESC/EACTS Guidelines on myocardial revascularization.
Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, Fernando Alfonso, Adrian P Banning, Umberto Benedetto, Robert A Byrne, Jean-Philippe Collet, Volkmar Falk, Stuart J Head,[...]. Eur Heart J 2019
14

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.
Dirk Sibbing, Daniel Aradi, Dimitrios Alexopoulos, Jurrien Ten Berg, Deepak L Bhatt, Laurent Bonello, Jean-Philippe Collet, Thomas Cuisset, Francesco Franchi, Lisa Gross,[...]. JACC Cardiovasc Interv 2019
172
14

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
Matthew T Roe, Paul W Armstrong, Keith A A Fox, Harvey D White, Dorairaj Prabhakaran, Shaun G Goodman, Jan H Cornel, Deepak L Bhatt, Peter Clemmensen, Felipe Martinez,[...]. N Engl J Med 2012
566
13

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
Borja Ibanez, Stefan James, Stefan Agewall, Manuel J Antunes, Chiara Bucciarelli-Ducci, Héctor Bueno, Alida L P Caforio, Filippo Crea, John A Goudevenos, Sigrun Halvorsen,[...]. Eur Heart J 2018
13

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen, Lisa Gross, Dietmar Trenk, Tobias Geisler, Martin Orban, Martin Hadamitzky, Béla Merkely, Róbert Gábor Kiss,[...]. Lancet 2017
242
13

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Naveen L Pereira, Michael E Farkouh, Derek So, Ryan Lennon, Nancy Geller, Verghese Mathew, Malcolm Bell, Jang-Ho Bae, Myung Ho Jeong, Ivan Chavez,[...]. JAMA 2020
84
15

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset,[...]. Eur Heart J 2020
12

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, Masahiro Natsuaki, Hiroki Shiomi, Toshiaki Toyota, Masanobu Ohya, Satoru Suwa, Kensuke Takagi, Mamoru Nanasato,[...]. JAMA 2019
307
12

Clinical end points in coronary stent trials: a case for standardized definitions.
Donald E Cutlip, Stephan Windecker, Roxana Mehran, Ashley Boam, David J Cohen, Gerrit-Anne van Es, P Gabriel Steg, Marie-angèle Morel, Laura Mauri, Pascal Vranckx,[...]. Circulation 2007
11

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
S R Mehta, S Yusuf, R J Peters, M E Bertrand, B S Lewis, M K Natarajan, K Malmberg, H Rupprecht, F Zhao, S Chrolavicius,[...]. Lancet 2001
11

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
C Michael Gibson, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W Verheugt, Peter Wildgoose, Mary Birmingham, Juliana Ianus, Paul Burton, Martin van Eickels,[...]. N Engl J Med 2016
808
11

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
Philip Urban, Roxana Mehran, Roisin Colleran, Dominick J Angiolillo, Robert A Byrne, Davide Capodanno, Thomas Cuisset, Donald Cutlip, Pedro Eerdmans, John Eikelboom,[...]. Eur Heart J 2019
139
11


2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Glenn N Levine, Eric R Bates, John A Bittl, Ralph G Brindis, Stephan D Fihn, Lee A Fleisher, Christopher B Granger, Richard A Lange, Michael J Mack, Laura Mauri,[...]. J Am Coll Cardiol 2016
760
11

Cytochrome p-450 polymorphisms and response to clopidogrel.
Jessica L Mega, Sandra L Close, Stephen D Wiviott, Lei Shen, Richard D Hockett, John T Brandt, Joseph R Walker, Elliott M Antman, William Macias, Eugene Braunwald,[...]. N Engl J Med 2009
10

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.
Jessica L Mega, Sandra L Close, Stephen D Wiviott, Lei Shen, Richard D Hockett, John T Brandt, Joseph R Walker, Elliott M Antman, William L Macias, Eugene Braunwald,[...]. Circulation 2009
484
10

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Christopher P Cannon, Deepak L Bhatt, Jonas Oldgren, Gregory Y H Lip, Stephen G Ellis, Takeshi Kimura, Michael Maeng, Bela Merkely, Uwe Zeymer, Savion Gropper,[...]. N Engl J Med 2017
678
10

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.
Guillaume Cayla, Thomas Cuisset, Johanne Silvain, Florence Leclercq, Stephane Manzo-Silberman, Christophe Saint-Etienne, Nicolas Delarche, Anne Bellemain-Appaix, Grégoire Range, Rami El Mahmoud,[...]. Lancet 2016
197
10


Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.
Francesco Costa, David van Klaveren, Stefan James, Dik Heg, Lorenz Räber, Fausto Feres, Thomas Pilgrim, Myeong-Ki Hong, Hyo-Soo Kim, Antonio Colombo,[...]. Lancet 2017
474
9

Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.
Gilles Montalescot, Leonardo Bolognese, Dariusz Dudek, Patrick Goldstein, Christian Hamm, Jean-Francois Tanguay, Jurrien M ten Berg, Debra L Miller, Timothy M Costigan, Jochen Goedicke,[...]. N Engl J Med 2013
333
9

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.
Thomas Cuisset, Pierre Deharo, Jacques Quilici, Thomas W Johnson, Stéphanie Deffarges, Clémence Bassez, Guillaume Bonnet, Laurent Fourcade, Jean Philippe Mouret, Marc Lambert,[...]. Eur Heart J 2017
178
9

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
Renato D Lopes, Gretchen Heizer, Ronald Aronson, Amit N Vora, Tyler Massaro, Roxana Mehran, Shaun G Goodman, Stephan Windecker, Harald Darius, Jia Li,[...]. N Engl J Med 2019
421
9

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
Joo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, Woo Jung Chun, Yong Hawn Park, Woo Jin Jang, Eul-Soon Im, Jin-Ok Jeong, Byung Ryul Cho, Seok Kyu Oh,[...]. JAMA 2019
211
9

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.
Lars Wallentin, Stefan James, Robert F Storey, Martin Armstrong, Bryan J Barratt, Jay Horrow, Steen Husted, Hugo Katus, P Gabriel Steg, Svati H Shah,[...]. Lancet 2010
553
9

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
S A Scott, K Sangkuhl, C M Stein, J-S Hulot, J L Mega, D M Roden, T E Klein, M S Sabatine, J A Johnson, A R Shuldiner. Clin Pharmacol Ther 2013
555
9

Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study.
Shigeru Saito, Takaaki Isshiki, Takeshi Kimura, Hisao Ogawa, Hiroyoshi Yokoi, Shinsuke Nanto, Morimasa Takayama, Kazuo Kitagawa, Masakatsu Nishikawa, Shunichi Miyazaki,[...]. Circ J 2014
193
8

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
Robert W Yeh, Eric A Secemsky, Dean J Kereiakes, Sharon-Lise T Normand, Anthony H Gershlick, David J Cohen, John A Spertus, Philippe Gabriel Steg, Donald E Cutlip, Michael J Rinaldi,[...]. JAMA 2016
508
8

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.
Dominick J Angiolillo, Fabiana Rollini, Robert F Storey, Deepak L Bhatt, Stefan James, David J Schneider, Dirk Sibbing, Derek Y F So, Dietmar Trenk, Dimitrios Alexopoulos,[...]. Circulation 2017
180
8

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Pascal Vranckx, Marco Valgimigli, Lars Eckardt, Jan Tijssen, Thorsten Lewalter, Giuseppe Gargiulo, Valerii Batushkin, Gianluca Campo, Zoreslava Lysak, Igor Vakaliuk,[...]. Lancet 2019
241
8

Bedside monitoring to adjust antiplatelet therapy for coronary stenting.
Jean-Philippe Collet, Thomas Cuisset, Grégoire Rangé, Guillaume Cayla, Simon Elhadad, Christophe Pouillot, Patrick Henry, Pascal Motreff, Didier Carrié, Ziad Boueri,[...]. N Engl J Med 2012
636
8

Genetic determinants of response to clopidogrel and cardiovascular events.
Tabassome Simon, Céline Verstuyft, Murielle Mary-Krause, Lina Quteineh, Elodie Drouet, Nicolas Méneveau, P Gabriel Steg, Jean Ferrières, Nicolas Danchin, Laurent Becquemont. N Engl J Med 2009
8

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.
Willem J M Dewilde, Tom Oirbans, Freek W A Verheugt, Johannes C Kelder, Bart J G L De Smet, Jean-Paul Herrman, Tom Adriaenssens, Mathias Vrolix, Antonius A C M Heestermans, Marije M Vis,[...]. Lancet 2013
7

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison.
Davide Capodanno, Fernando Alfonso, Glenn N Levine, Marco Valgimigli, Dominick J Angiolillo. J Am Coll Cardiol 2018
139
7


Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
Jessica L Mega, Tabassome Simon, Jean-Philippe Collet, Jeffrey L Anderson, Elliott M Antman, Kevin Bliden, Christopher P Cannon, Nicolas Danchin, Betti Giusti, Paul Gurbel,[...]. JAMA 2010
728
7

Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial.
Francesca Maria Notarangelo, Giuseppe Maglietta, Paola Bevilacqua, Marco Cereda, Piera Angelica Merlini, Giovanni Quinto Villani, Paolo Moruzzi, Giampiero Patrizi, Guidantonio Malagoli Tagliazucchi, Antonio Crocamo,[...]. J Am Coll Cardiol 2018
86
8

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.
Paul A Gurbel, Kevin P Bliden, Kathleen Butler, Udaya S Tantry, Tania Gesheff, Cheryl Wei, Renli Teng, Mark J Antonino, Shankar B Patil, Arun Karunakaran,[...]. Circulation 2009
798
7

Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
Byeong-Keuk Kim, Sung-Jin Hong, Yun-Hyeong Cho, Kyeong Ho Yun, Yong Hoon Kim, Yongsung Suh, Jae Young Cho, Ae-Young Her, Sungsoo Cho, Dong Woon Jeon,[...]. JAMA 2020
104
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.